Jarrett Jennifer sold RCUS
October 6, 2025 · Form 4 insider transaction
Jarrett Jennifer sold 12,500 shares of Arcus Biosciences, Inc. at $14.54 per share, a transaction worth $181.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.; Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.